Exercise Testing for Heart Injury Detection After Surgery
(EnhanceMINS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a type of exercise test, called Submaximal Cardiopulmonary Exercise Testing, to determine if it can better detect heart injuries after surgery compared to usual methods. It focuses on patients scheduled for moderate to high-risk, non-cardiac surgeries. The trial aims to identify which part of the exercise test most effectively spots these injuries. Individuals who can climb a flight of stairs and are set for surgery soon might be suitable for this study. As an unphased study, this trial offers a unique opportunity to contribute to innovative research that could improve surgical outcomes.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that submaximal cardiopulmonary exercise testing is safe for detecting myocardial injury after surgery?
Research has shown that submaximal cardiopulmonary exercise testing is generally safe for patients. Studies have found that this test effectively assesses heart function without causing harm. Most individuals, even those with heart conditions, tolerate it well.
Significant problems directly linked to submaximal exercise testing have not been reported, suggesting it is unlikely to cause major issues. This test is less intense than full exercise tests, reducing stress on the heart.
Although this trial does not focus on treatment safety, the exercise test itself has been safely used in various settings to better understand heart health. This background provides assurance about the test's safety for participants.12345Why are researchers excited about this trial?
Researchers are excited about submaximal cardiopulmonary exercise testing because it offers a novel way to detect heart injury after surgery, which is crucial for timely intervention. Unlike standard methods that rely primarily on symptom evaluation and basic cardiac monitoring, this approach combines exercise testing with high-sensitivity troponin measurements to provide a more precise assessment of heart function and potential damage. This method could lead to earlier and more accurate detection of heart issues, allowing for better management and improved outcomes for patients post-surgery.
What evidence suggests that submaximal cardiopulmonary exercise testing is effective for detecting myocardial injury after surgery?
Studies have shown that submaximal cardiopulmonary exercise testing (CPET) can help predict post-surgery problems. Research indicates that CPET results effectively assess pre-surgery risk and forecast potential heart issues afterward. Early findings suggest CPET might identify early complications more effectively than traditional methods. This trial will involve participants receiving submaximal CPET alongside usual care to evaluate its effectiveness in detecting post-surgery heart problems. The test assesses heart and lung function during exercise, aiding in the identification of potential heart issues after surgery. With this information, doctors can better manage and reduce the risk of heart complications following surgery.13678
Who Is on the Research Team?
Zyad J Carr, M.D.
Principal Investigator
Yale University
Are You a Good Fit for This Trial?
This trial is for individuals undergoing non-cardiac surgery who will be assessed for myocardial injury, which is heart damage that can occur after surgery. Participants must be able to perform a submaximal cardiopulmonary exercise test before their operation.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Preoperative Evaluation
Participants undergo submaximal cardiopulmonary exercise testing to assess preoperative risk
Surgery and Immediate Postoperative Monitoring
Participants undergo surgery and are monitored for myocardial injury using high-sensitivity troponin measurements on operative day 0 and postoperative days 1, 2, and 3
Follow-up
Participants are monitored for major adverse cardiovascular events and other outcomes up to 30 days post-surgery
Extended Follow-up
Participants are monitored for readmission and length of stay up to 60 days post-surgery
What Are the Treatments Tested in This Trial?
Interventions
- Submaximal Cardiopulmonary Exercise Testing
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor